nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—HTR1B—attention deficit hyperactivity disorder	0.806	1	CbGaD
Bopindolol—Carvedilol—ADRA2C—attention deficit hyperactivity disorder	0.0022	0.558	CrCbGaD
Bopindolol—Carvedilol—ADRA2A—attention deficit hyperactivity disorder	0.00094	0.238	CrCbGaD
Bopindolol—HTR1B—forebrain—attention deficit hyperactivity disorder	0.000861	0.0931	CbGeAlD
Bopindolol—ADRB1—forebrain—attention deficit hyperactivity disorder	0.00081	0.0876	CbGeAlD
Bopindolol—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.000807	0.204	CrCbGaD
Bopindolol—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000728	0.0787	CbGeAlD
Bopindolol—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000695	0.0751	CbGeAlD
Bopindolol—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000685	0.074	CbGeAlD
Bopindolol—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000588	0.0635	CbGeAlD
Bopindolol—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000569	0.0615	CbGeAlD
Bopindolol—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000468	0.0505	CbGeAlD
Bopindolol—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000459	0.0496	CbGeAlD
Bopindolol—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.00045	0.0486	CbGeAlD
Bopindolol—ADRB1—nervous system—attention deficit hyperactivity disorder	0.00044	0.0475	CbGeAlD
Bopindolol—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.000423	0.0458	CbGeAlD
Bopindolol—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000377	0.0408	CbGeAlD
Bopindolol—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000363	0.0393	CbGeAlD
Bopindolol—HTR1B—brain—attention deficit hyperactivity disorder	0.000357	0.0386	CbGeAlD
Bopindolol—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000355	0.0384	CbGeAlD
Bopindolol—ADRB1—brain—attention deficit hyperactivity disorder	0.000336	0.0363	CbGeAlD
Bopindolol—HTR1A—brain—attention deficit hyperactivity disorder	0.000288	0.0312	CbGeAlD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000168	0.000931	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000168	0.000929	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000168	0.000927	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000165	0.000913	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000165	0.000911	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000164	0.000907	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000163	0.000902	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000163	0.000902	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000162	0.000896	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000161	0.00089	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00016	0.000887	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00016	0.000886	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000159	0.000882	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000158	0.000877	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000158	0.000875	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000157	0.000867	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000156	0.000862	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000155	0.000858	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000155	0.000856	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.000848	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000152	0.000842	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000152	0.00084	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000152	0.000839	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000151	0.000838	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000151	0.000837	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000149	0.000824	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000149	0.000824	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000148	0.000821	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000148	0.000817	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000147	0.000815	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000146	0.000806	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000144	0.000798	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000144	0.000798	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000141	0.000781	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000141	0.00078	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000141	0.00078	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00014	0.000772	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000138	0.000765	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000138	0.000763	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000138	0.000763	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000137	0.000759	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000137	0.000756	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000135	0.00075	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000135	0.000747	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000134	0.000743	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000134	0.000739	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000133	0.000739	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000133	0.000734	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000132	0.000731	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000131	0.000726	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000131	0.000726	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00013	0.000717	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00013	0.000717	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00013	0.000717	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000129	0.000715	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000129	0.000712	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000128	0.000709	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000126	0.000699	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000126	0.000695	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000123	0.000683	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000121	0.000668	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000121	0.000668	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000118	0.000654	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000118	0.000653	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000117	0.000646	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000115	0.000639	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000113	0.000628	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000113	0.000625	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000113	0.000625	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000112	0.000622	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000112	0.000622	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000111	0.000614	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00011	0.000609	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00011	0.000608	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00011	0.000607	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000108	0.000596	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000108	0.000595	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000107	0.000594	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000106	0.000588	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000105	0.000583	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000105	0.000581	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000104	0.000578	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000104	0.000578	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000104	0.000575	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000103	0.000571	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000103	0.000571	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.000566	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000102	0.000565	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000102	0.000565	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000102	0.000563	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000102	0.000562	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000101	0.00056	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000101	0.000559	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000101	0.000559	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0001	0.000553	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	9.99e-05	0.000553	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.98e-05	0.000553	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	9.95e-05	0.000551	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	9.95e-05	0.000551	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.87e-05	0.000546	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.87e-05	0.000546	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	9.82e-05	0.000544	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.78e-05	0.000541	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.76e-05	0.00054	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	9.76e-05	0.00054	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.61e-05	0.000532	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	9.58e-05	0.00053	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.56e-05	0.000529	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.49e-05	0.000525	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.4e-05	0.00052	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.19e-05	0.000509	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.19e-05	0.000509	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.15e-05	0.000507	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	9.03e-05	0.0005	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.99e-05	0.000498	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.92e-05	0.000494	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.84e-05	0.000489	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	8.81e-05	0.000488	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.79e-05	0.000487	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	8.7e-05	0.000482	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.65e-05	0.000479	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.6e-05	0.000476	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.46e-05	0.000468	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	8.45e-05	0.000468	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.31e-05	0.00046	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	7.82e-05	0.000433	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	7.79e-05	0.000431	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.63e-05	0.000422	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.57e-05	0.000419	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	7.54e-05	0.000417	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.47e-05	0.000413	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.42e-05	0.00041	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	7.41e-05	0.00041	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	7.32e-05	0.000405	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.3e-05	0.000404	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	7.27e-05	0.000403	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	7.07e-05	0.000391	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.02e-05	0.000388	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.93e-05	0.000384	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.9e-05	0.000382	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.86e-05	0.00038	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.85e-05	0.000379	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.82e-05	0.000377	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.78e-05	0.000375	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.73e-05	0.000373	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.73e-05	0.000373	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.71e-05	0.000371	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.67e-05	0.000369	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.65e-05	0.000368	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.63e-05	0.000367	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.59e-05	0.000364	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.53e-05	0.000361	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.44e-05	0.000356	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.41e-05	0.000355	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.38e-05	0.000353	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.2e-05	0.000343	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.19e-05	0.000343	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.07e-05	0.000336	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.06e-05	0.000335	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.03e-05	0.000334	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.03e-05	0.000334	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.01e-05	0.000332	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.93e-05	0.000328	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.93e-05	0.000328	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.91e-05	0.000327	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.9e-05	0.000327	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.9e-05	0.000326	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.88e-05	0.000325	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.83e-05	0.000323	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.82e-05	0.000322	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.79e-05	0.000321	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.79e-05	0.000321	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.78e-05	0.00032	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.78e-05	0.00032	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.77e-05	0.000319	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.75e-05	0.000318	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.7e-05	0.000316	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.67e-05	0.000314	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.65e-05	0.000313	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.65e-05	0.000313	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.63e-05	0.000312	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.61e-05	0.00031	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.58e-05	0.000309	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.54e-05	0.000307	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.51e-05	0.000305	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.45e-05	0.000302	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.43e-05	0.000301	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.43e-05	0.0003	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.39e-05	0.000298	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.36e-05	0.000297	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.34e-05	0.000295	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.34e-05	0.000295	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.31e-05	0.000294	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.3e-05	0.000293	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.27e-05	0.000292	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.24e-05	0.00029	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.22e-05	0.000289	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.2e-05	0.000288	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.18e-05	0.000287	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.14e-05	0.000285	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.13e-05	0.000284	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.06e-05	0.00028	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.93e-05	0.000273	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.91e-05	0.000272	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.83e-05	0.000267	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.78e-05	0.000264	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.72e-05	0.000261	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.34e-05	0.00024	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.18e-05	0.000231	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.09e-05	0.000227	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.05e-05	0.000224	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.01e-05	0.000222	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.98e-05	0.00022	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.93e-05	0.000217	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.92e-05	0.000217	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.8e-05	0.000211	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.72e-05	0.000206	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.66e-05	0.000203	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.64e-05	0.000201	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.58e-05	0.000198	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.5e-05	0.000194	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.45e-05	0.000191	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.44e-05	0.00019	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.42e-05	0.000189	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.38e-05	0.000187	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.33e-05	0.000184	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.3e-05	0.000183	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.25e-05	0.00018	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.22e-05	0.000178	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.18e-05	0.000176	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.17e-05	0.000175	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.15e-05	0.000174	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.13e-05	0.000173	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.1e-05	0.000171	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.08e-05	0.000171	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.06e-05	0.000169	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.03e-05	0.000168	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.99e-05	0.000166	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.91e-05	0.000161	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.85e-05	0.000158	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.79e-05	0.000154	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.56e-05	0.000142	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.04e-05	0.000113	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2e-05	0.00011	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.95e-05	0.000108	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.82e-05	0.000101	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.36e-05	7.51e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.08e-05	5.98e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.06e-05	5.85e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.03e-05	5.72e-05	CbGpPWpGaD
